MX2019003191A - Microorganismos oxidantes de amoníaco para uso y suministro al sistema intranasal. - Google Patents
Microorganismos oxidantes de amoníaco para uso y suministro al sistema intranasal.Info
- Publication number
- MX2019003191A MX2019003191A MX2019003191A MX2019003191A MX2019003191A MX 2019003191 A MX2019003191 A MX 2019003191A MX 2019003191 A MX2019003191 A MX 2019003191A MX 2019003191 A MX2019003191 A MX 2019003191A MX 2019003191 A MX2019003191 A MX 2019003191A
- Authority
- MX
- Mexico
- Prior art keywords
- ammonia oxidizing
- delivery
- intranasal system
- intranasal
- preparations
- Prior art date
Links
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 title abstract 12
- 229910021529 ammonia Inorganic materials 0.000 title abstract 6
- 230000001590 oxidative effect Effects 0.000 title abstract 6
- 244000005700 microbiome Species 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 2
- 208000026344 Nasal disease Diseases 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 208000030880 Nose disease Diseases 0.000 abstract 1
- 208000018920 Paranasal Sinus disease Diseases 0.000 abstract 1
- 208000028347 Sinus disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
- Inorganic Chemistry (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Child & Adolescent Psychology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662397642P | 2016-09-21 | 2016-09-21 | |
| PCT/US2017/052671 WO2018057710A1 (en) | 2016-09-21 | 2017-09-21 | Ammonia oxidizing microorganisms for use and delivery to the intranasal system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019003191A true MX2019003191A (es) | 2019-12-05 |
Family
ID=60022194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019003191A MX2019003191A (es) | 2016-09-21 | 2017-09-21 | Microorganismos oxidantes de amoníaco para uso y suministro al sistema intranasal. |
Country Status (14)
| Country | Link |
|---|---|
| US (6) | US20200016216A1 (https=) |
| EP (1) | EP3515464B1 (https=) |
| JP (1) | JP2019532933A (https=) |
| KR (1) | KR20190055159A (https=) |
| CN (1) | CN110191716A (https=) |
| AU (1) | AU2017332347A1 (https=) |
| BR (1) | BR112019005536A2 (https=) |
| CA (1) | CA3037703A1 (https=) |
| IL (1) | IL265508A (https=) |
| MX (1) | MX2019003191A (https=) |
| PH (1) | PH12019500622A1 (https=) |
| RU (1) | RU2019111715A (https=) |
| SG (1) | SG10202109410XA (https=) |
| WO (1) | WO2018057710A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210100224A (ko) * | 2014-04-15 | 2021-08-13 | 에이오바이오미 엘엘씨 | 암모니아-산화 니트로소모나스 유트로파 균주 d23 |
| WO2019018425A1 (en) * | 2017-07-18 | 2019-01-24 | Aobiome Llc | AMMONIA-OXIDIZING MICROORGANISMS FOR INJECTION USE AND ADMINISTRATION |
| WO2019018348A1 (en) * | 2017-07-18 | 2019-01-24 | Aobiome Llc | AMMONIA-OXIDIZING MICROORGANISMS FOR UTILIZATION AND ADMINISTRATION AT THE UROGENITAL SYSTEM |
| US20200206278A1 (en) * | 2017-07-18 | 2020-07-02 | Aobiome Llc | Ammonia oxidizing microorganisms for the treatment of pulmonary hypertension |
| EP3654999A4 (en) * | 2017-07-18 | 2021-03-31 | Aobiome LLC | AMMONIA COXIDIZING MICROORGANISMS FOR THE TREATMENT OF HEADACHE |
| US10883260B2 (en) * | 2018-01-17 | 2021-01-05 | Andrew Lee Reger | Scent barrier and dispenser |
| KR102831159B1 (ko) | 2018-04-16 | 2025-07-07 | 온퀄리티 파마슈티컬스 차이나 리미티드 | 암 치료의 부작용을 예방하거나 치료하기 위한 방법 |
| WO2022147585A1 (en) * | 2020-12-31 | 2022-07-07 | Ntby Moss Llc | Formulations of a prophylactic nasal spray and methods of use and manufacture thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1243390B (it) | 1990-11-22 | 1994-06-10 | Vectorpharma Int | Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione. |
| FR2774674B1 (fr) | 1998-02-10 | 2000-03-24 | Atochem Elf Sa | Procede de preparation d'une solution aqueuse de peroxyde d'hydrogene directement a partir d'hydrogene et d'oxygene et dispositif permettant sa mise en oeuvre |
| KR20030065463A (ko) | 2000-08-11 | 2003-08-06 | 데이비드 알. 휘트록 | 질소 산화물 및 질소 산화물 전구체의 생산을 증가시키기위한 암모니아 산화 박테리아를 포함하는 조성물 및 이를이용하는 방법 |
| KR20210100224A (ko) * | 2014-04-15 | 2021-08-13 | 에이오바이오미 엘엘씨 | 암모니아-산화 니트로소모나스 유트로파 균주 d23 |
| US10383900B2 (en) * | 2014-05-22 | 2019-08-20 | Aobiome Llc | Systems and methods for storage and delivery of ammonia oxidizing bacteria |
| CA2949833C (en) | 2014-05-22 | 2024-06-11 | Aobiome Llc | Methods of preparing materials with ammonia oxidizing bacteria and testing materials for ammonia oxidizing bacteria |
| WO2016161285A1 (en) * | 2015-04-02 | 2016-10-06 | Aobiome Llc | Production of nitro-fatty acids and nitro-hydrocarbons by ammonia oxidizing bacteria |
| CN109069878A (zh) | 2015-07-02 | 2018-12-21 | Ao生物医学有限责任公司 | 微生物群系相容性化妆品 |
| WO2017004557A1 (en) * | 2015-07-02 | 2017-01-05 | Aobiome Llc | Ammonia oxidizing bacteria for treatment of acne |
-
2017
- 2017-09-21 BR BR112019005536A patent/BR112019005536A2/pt not_active Application Discontinuation
- 2017-09-21 CA CA3037703A patent/CA3037703A1/en active Pending
- 2017-09-21 KR KR1020197010958A patent/KR20190055159A/ko not_active Ceased
- 2017-09-21 MX MX2019003191A patent/MX2019003191A/es unknown
- 2017-09-21 SG SG10202109410X patent/SG10202109410XA/en unknown
- 2017-09-21 AU AU2017332347A patent/AU2017332347A1/en not_active Abandoned
- 2017-09-21 CN CN201780071609.XA patent/CN110191716A/zh active Pending
- 2017-09-21 EP EP17780585.0A patent/EP3515464B1/en active Active
- 2017-09-21 JP JP2019515834A patent/JP2019532933A/ja active Pending
- 2017-09-21 WO PCT/US2017/052671 patent/WO2018057710A1/en not_active Ceased
- 2017-09-21 RU RU2019111715A patent/RU2019111715A/ru unknown
- 2017-09-21 US US16/335,434 patent/US20200016216A1/en not_active Abandoned
-
2019
- 2019-03-20 IL IL265508A patent/IL265508A/en unknown
- 2019-03-21 PH PH12019500622A patent/PH12019500622A1/en unknown
-
2022
- 2022-07-15 US US17/812,889 patent/US20220347230A1/en not_active Abandoned
-
2023
- 2023-01-26 US US18/160,007 patent/US20230172998A1/en not_active Abandoned
- 2023-08-25 US US18/238,167 patent/US20230398157A1/en not_active Abandoned
-
2025
- 2025-04-10 US US19/175,409 patent/US20250235489A1/en not_active Abandoned
- 2025-11-13 US US19/388,926 patent/US20260069642A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| RU2019111715A (ru) | 2020-10-26 |
| US20230398157A1 (en) | 2023-12-14 |
| US20230172998A1 (en) | 2023-06-08 |
| JP2019532933A (ja) | 2019-11-14 |
| SG10202109410XA (en) | 2021-10-28 |
| IL265508A (en) | 2019-05-30 |
| CA3037703A1 (en) | 2018-03-29 |
| CN110191716A (zh) | 2019-08-30 |
| KR20190055159A (ko) | 2019-05-22 |
| EP3515464B1 (en) | 2025-11-05 |
| BR112019005536A2 (pt) | 2019-06-25 |
| PH12019500622A1 (en) | 2019-11-11 |
| US20220347230A1 (en) | 2022-11-03 |
| WO2018057710A1 (en) | 2018-03-29 |
| US20260069642A1 (en) | 2026-03-12 |
| EP3515464A1 (en) | 2019-07-31 |
| US20250235489A1 (en) | 2025-07-24 |
| AU2017332347A1 (en) | 2019-04-18 |
| US20200016216A1 (en) | 2020-01-16 |
| RU2019111715A3 (https=) | 2021-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019500622A1 (en) | Ammonia oxidixing microorganisms for use and delivery to the intranasal system | |
| PH12019502725A1 (en) | Use of lactic acid bacteria to treat or prevent at least one of postnatal depression and postnatal anxiety | |
| PH12019500521A1 (en) | Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer | |
| MX2020011783A (es) | Terapia de combinacion que involucra anticuerpos contra claudina 18.2 para tratamiento de cancer. | |
| MX2021001186A (es) | Purinonas como inhibidores de proteasa especifica de ubiquitina 1. | |
| EP3712264A8 (en) | Cystathionine beta-synthase enzyme for treatment of homocystinuria | |
| EP4417262A3 (en) | Combination therapy | |
| EP4335517A3 (en) | Administration and dosage of diaminophenothiazines | |
| MX2019008124A (es) | Metodos para el tratamiento de trastornos neurologicos. | |
| EP3654936A4 (en) | AMMONIA-COXIDIZING MICRO-ORGANISMS FOR USE AND ADMINISTRATION TO THE UROGENITAL TRACT | |
| PH12017501300A1 (en) | Novel iodophor composition and methods of use | |
| PH12020550023A1 (en) | Compositions for treating stress-related disorders | |
| MX2019006552A (es) | Terapia génica para mucopolisacaridosis de tipo i. | |
| MX2020003219A (es) | Anticuerpos que tienen especificidad para btn2 y usos de los mismos. | |
| EP4487912A3 (en) | Improved treatment of atopic dermatitis with tradipitant | |
| AU2018337076A1 (en) | Method of treatment | |
| AU2018253600A1 (en) | Dosage forms and therapeutic uses of l-4-chlorokynurenine | |
| CA3010708A1 (en) | Methods of administering hepcidin | |
| PH12016501371A1 (en) | Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same | |
| MX2020012263A (es) | Compuestos antibacterianos. | |
| PH12021551419A1 (en) | New conjugated nucleic acid molecules and their uses | |
| MY194135A (en) | Treatment and diagnosis of inflammatory disorders | |
| MY198500A (en) | Cancer treatment | |
| EP3662934A4 (en) | COMPOSITION FOR GENE THERAPY OF THE CENTRAL NERVOUS SYSTEM, METHOD FOR PRODUCING IT AND USING IT | |
| SG10201903630UA (en) | Iminosugars useful for the treatment of viral diseases |